TY - JOUR
T1 - Quantifying the learning curve in the use of a novel vascular closure device
T2 - An analysis of the NCDR (national cardiovascular data registry) CathPCI registry
AU - Resnic, Frederic S.
AU - Wang, Tracy Y.
AU - Arora, Nipun
AU - Vidi, Venkatesan
AU - Dai, David
AU - Ou, Fang Shu
AU - Matheny, Michael E.
N1 - Funding Information:
This study was funded, in part, by grants from National Library of Medicine ( NIH R01-LM008142 ), the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR), as well as by the Veteran's Administration Health Services Research and Development Service ( CDP 09-387 ).
PY - 2012/1
Y1 - 2012/1
N2 - This study sought to quantify the learning curve for the safety and effectiveness of a newly introduced vascular closure device through evaluation of the NCDR (National Cardiovascular Data Registry) CathPCI clinical outcomes registry. The impact of learning on the clinical outcomes complicates the assessment of the safety and efficacy during the early experience with newly introduced medical devices. We performed a retrospective analysis of the relationship between cumulative institutional experience and clinical device success, defined as device deployment success and freedom from any vascular complications, for the StarClose vascular closure device (Abbott Vascular, Redwood City, California). Generalized estimating equation modeling was used to develop risk-adjusted clinical success predictions that were analyzed to quantify learning curve rates. A total of 107,710 procedures used at least 1 StarClose deployment, between January 1, 2006, and December 31, 2007, with overall clinical success increasing from 93% to 97% during the study period. The learning curve was triphasic, with an initial rapid learning phase, followed by a period of declining rates of success, followed finally by a recovery to a steady-state rate of improved device success. The rates of learning were influenced positively by diagnostic (vs. percutaneous coronary intervention) procedure use and teaching status and were affected inversely by annual institutional volume. An institutional-level learning curve for the initial national experience of StarClose was triphasic, likely indicating changes in patient selection and expansion of number of operators during the initial phases of device adoption. The rate of learning was influenced by several institutional factors, including overall procedural volume, utilization for percutaneous coronary intervention procedures, and teaching status.
AB - This study sought to quantify the learning curve for the safety and effectiveness of a newly introduced vascular closure device through evaluation of the NCDR (National Cardiovascular Data Registry) CathPCI clinical outcomes registry. The impact of learning on the clinical outcomes complicates the assessment of the safety and efficacy during the early experience with newly introduced medical devices. We performed a retrospective analysis of the relationship between cumulative institutional experience and clinical device success, defined as device deployment success and freedom from any vascular complications, for the StarClose vascular closure device (Abbott Vascular, Redwood City, California). Generalized estimating equation modeling was used to develop risk-adjusted clinical success predictions that were analyzed to quantify learning curve rates. A total of 107,710 procedures used at least 1 StarClose deployment, between January 1, 2006, and December 31, 2007, with overall clinical success increasing from 93% to 97% during the study period. The learning curve was triphasic, with an initial rapid learning phase, followed by a period of declining rates of success, followed finally by a recovery to a steady-state rate of improved device success. The rates of learning were influenced positively by diagnostic (vs. percutaneous coronary intervention) procedure use and teaching status and were affected inversely by annual institutional volume. An institutional-level learning curve for the initial national experience of StarClose was triphasic, likely indicating changes in patient selection and expansion of number of operators during the initial phases of device adoption. The rate of learning was influenced by several institutional factors, including overall procedural volume, utilization for percutaneous coronary intervention procedures, and teaching status.
KW - angioplasty
KW - learning curve
KW - safety
KW - vascular closure devices
UR - http://www.scopus.com/inward/record.url?scp=84862953529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862953529&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2011.09.017
DO - 10.1016/j.jcin.2011.09.017
M3 - Article
C2 - 22230153
AN - SCOPUS:84862953529
SN - 1936-8798
VL - 5
SP - 82
EP - 89
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 1
ER -